Occult-blood screening for colorectal carcinoma: the risks

Area of Science:

• Gastroenterology
• Oncology
• Preventive Medicine

Background:

• Colorectal cancer screening aims to reduce morbidity and mortality.
• Occult-blood screening (Hemoccult) is a widely used method.
• Evidence for Hemoccult's benefit in reducing colorectal cancer mortality is limited.

Purpose of the Study:

• To examine the risks associated with occult-blood screening for colorectal cancer.
• To evaluate the benefit-risk ratio of Hemoccult screening across different age groups.

Main Methods:

• Analysis of potential harms from widespread Hemoccult screening.
• Assessment of the positive predictive value of Hemoccult in various age demographics.
• Evaluation of treatment likelihood post-diagnosis in screened populations.

Main Results:

• Widespread Hemoccult screening can lead to significant harm from extensive investigations for false-positive results.
• The highest positive predictive value for cancer is observed in individuals over 70.
• Older adults are less likely to undergo treatment for detected cancers.

Conclusions:

• The risks of Hemoccult screening may exceed its benefits for all age groups.
• The current evidence does not support widespread occult-blood screening for colorectal cancer.
• Further research is needed to establish the net benefit of colorectal cancer screening methods.